adMare BioInnovations

With a strong track record of globally competitive scientific discovery, Canadian life sciences is primed to lead the world. To make this a reality, adMare BioInnovations uses its scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems, and industry-ready talent. We re-invest our returns into the Canadian industry to ensure its long-term sustainability.

Our 29 portfolio companies have attracted more than $2.3 billion of risk capital, have a combined value of over $4 billion, and employ more than 1000 Canadians. Our Innovation Centres are home to 25+ biotech companies, contract research organizations, and specialized commercialization support organizations. The adMare Academy has trained more than 500 alumni – 94% of whom are now working to build our life sciences industry.

Commitment to Diversity

adMare is fully committed to the principles of equity, diversity, and inclusion; and to making them an integral part of our organizational strategy – a commitment that is not just about words but is about specific actions to create a barrier-free, respectful, and welcoming working environment wherein everyone feels welcomed, supported, included, valued, and empowered to succeed. We are also proud to be an early adopter of the Government of Canada’s 50–30 Challenge to achieve meaningful and substantive improvements in workplace diversity and inclusion at all levels of the organization, including positions of influence and senior leadership.

Vision for the Future

We are building Canada’s life science industry from sea to sea.